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1. Introduction
Lobar radioembolisation or selective internal radiation
therapy (SIRT) of the liver can result in ipsilateral
lobar volume reduction as well as in contralateral lobar
hypertrophy. 1−4 Theoretically, hypertrophy of the con-
tralateral liver lobe after SIRT could increase the chance
of a successful liver resection especially in patients
with limited liver function reserve. This preliminary
study aims to evaluate the early effects of SIRT with
yttrium-90 (90Y) resin microspheres on liver lobe and
spleen volumes.
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2. Methods
We retrospectively investigated 24 patients (12 female,
44−78 years old) with different types of cancer and liver-
dominant metastatic disease who underwent SIRT of
the liver with 90Y resin microspheres (SIR-Spheres, Sirtex
Medical) between 2008 and 2009.Volume alteration of the
liver lobes and spleen was quantiﬁed using computed
tomography scans before and approximately 4 to 8 weeks
after treatment.
3. Results
Seventeen patients had metastases in both liver lobes
(groupA) and 7 hadmetastases in the right liver lobe only
(group B). The patients in group A underwent sequential
treatment starting with the right liver lobe. The median
administered dose was 1.75GBq. SIRT was associated
with a median increase of 34% (P< 0.001) of the left lobe
volume (LLV) and a median decrease of 11% (P=0.03)
of the right lobe volume (RLV). The spleen volume (SV)
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showed a median increase of 17% (P=0.01). Separate
analysis of the two groups showed a median LLV increase
of 30% (P=0.001) in group A and 70% (P=0.01) in group B.
There was no correlation between the injected dose and
the volume alteration (0.1< r< 0.3).
4. Discussion
Hepatic malignancies are commonly unresectable both
at initial manifestation and at recurrence due to the
presence of extrahepatic disease and bilobar hepatic
involvement but also insufﬁcient remnant liver volume.
Both the risk of liver failure after resection as well as
postoperative morbidity are directly correlated to the
remnant liver volume. 5 The degree of hypertrophy after
portal vein embolisation ranges between 7% and 16%
at 4−8-week follow-up. 6 Our study revealed a more
prominent hypertrophy of LLV following SIRT with
90Y resin microspheres compared with portal vein
embolisation. This effect of SIRT was over and above our
main intention which was the treatment of the tumours
in the right lobe. Our results are in agreement with
other published studies investigating contralateral lobar
hypertrophy after SIRT. Such a hypertrophy has not been
reported after TACE.
5. Conclusion
SIRT of the right liver lobe with 90Y resin microspheres
causes a signiﬁcant increase in the LLV. This may
facilitate liver resection in patients with metastases in
the right hepatic lobe and a small left hepatic lobe.
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